Achievements

Achievements and Future Plans

Regulatory

ISO 9001: 2015 Certification by Perry Johnson Registrars, Inc. to Unit I, Hyderabad and Unit II, Visakhapatnam

ISO 14001: 2015 Certification by Perry Johnson Registrars, Inc. to Unit I, Hyderabad and Unit II, Visakhapatnam

OHSAS I8001:2007 Certification by Perry Johnson Registrars, Inc. to Unit I, Hyderbad and Unit II, Visakhapatnam

WHO GMP Certification to Unit I, Hyderabad

Schedule M-GMP Certification to Unit I,Hyderabad and Unit II, Hyderabad

USFDA EIR for Unit II, Visakhapatnam

CEP for Fluconazole and Terbinafine Hcl

Written Confirmation for 5 products- Fluconazole, Terbinafine Hcl, Escitalopram Oxalate, Losartan Potassium, Dapoxetine Hcl.

Awards

Business Partner Excellence Award from Dr. Reddy's Laboratories in 2016

Best Supplier Award from Dr. Reddy's Laboratories in 2014 

Patents

Process Patent granted for Escitalopram Oxalate

Process Patent granted for S (+) Dapoxetine Hcl

Process Patent applied for Luliconazole

Future Plans

A Greenfield project (Unit III) is being constructed at Jawaharlal Nehru Pharma City, Visakhapatnam across an area of 2.3 acres with a capital of 6 Million USD.